The apparently contradictory results regarding IGF-1 and asthma can be explained in part by the fact that preclinical models measured IGF-1 in the lungs, while epidemiological studies assessed circulating serum IGF-1 levels, which may have disparate impacts on and airway inflammation. Here, IGF1 is linked to asthma.